NASDAQ$SKIN
SkinHealth Systems Inc · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
SkinHealth Systems Inc reported Q2 2025 results with net sales of $78.2 million and net income of $19.7 million.
The Beauty Health Company delivered Q2 2025 net sales of $78.2 million, down 13.7% year-over-year, driven by lower Delivery Systems revenue partially offset by stable Consumables sales. The company achieved net income of $19.7 million, supported by a $18.1 million gain on convertible note exchanges and repurchases. Gross margin improved to 62.8% amid favorable product mix and reduced inventory charges.
- Q2 net sales totaled $78.2 million, with Consumables comprising 71.4% of revenue at $55.8 million.
- Net income reached $19.7 million, including an $18.1 million gain from 2026 Notes transactions.
- Gross profit rose to $49.1 million with gross margin expanding to 62.8% from 45.2% in Q2 2024.
- Cash, cash equivalents, and restricted cash stood at $212.0 million as of June 30, 2025.
Headline financials
Revenue & EPS history
Beauty Health · Revenue · Quarterly
$78.2M
Revenue by segment
Beauty Health · $78.2M total across 2 segments · Q2 2025
- Consumables$55.8M—71.4%
- Delivery Systems$22.4M—28.6%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
+0.6%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-1.9%
Avg return
30 days after
52%
12 / 23 earnings
Positive
+52.1%
Q1 2025
Best reaction
-61.4%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | -2.5% | -29.9% | -34.9% | |
| Q4 2025 | +19.8% | +11.3% | -15.3% | |
| Q3 2025 | +8.7% | +3.1% | +13.2% | |
| Q1 2025 | +52.1% | +19.4% | +29.0% | |
| Q4 2024 | -5.6% | -9.9% | -26.1% | |
| Q3 2024 | +5.1% | -13.1% | -14.2% | |
| Q2 2024 | -10.4% | +0.8% | +12.8% | |
| Q1 2024 | -20.1% | -18.4% | -39.9% | |
| Q4 2023 | +16.8% | -0.8% | +4.4% | |
| Q3 2023 | -61.4% | -37.2% | -14.7% | |
| Q2 2023 | -6.0% | -12.9% | -24.2% | |
| Q1 2023 | -2.8% | -0.2% | -20.8% | |
| Q4 2022 | +8.7% | +13.5% | +7.4% | |
| Q3 2022 | -25.3% | -12.3% | -4.1% | |
| Q2 2022 | -8.3% | -8.8% | -18.5% | |
| Q1 2022 | -5.4% | +6.6% | +8.9% | |
| Q4 2019 | +4.0% | -4.1% | -12.9% | |
| Q4 2021 | +23.4% | +43.1% | +27.6% | |
| Q3 2021 | -11.9% | -8.0% | -13.9% | |
| Q2 2020 | +8.2% | +7.4% | +26.8% | |
| Q2 2021 | +10.6% | +23.9% | +30.3% | |
| Q1 2021 | +12.8% | +15.9% | +44.7% | |
| Q4 2020 | +2.8% | -0.9% | -10.0% | |
| Q3 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro